

Cover Story
FreeNews Analysis
By Matthew Bin Han Ong
Now that Joseph R. Biden Jr. is inaugurated and safely ensconced in the White House, cancer groups expect him to pick up where he left off as vice president four years ago—pursuing a sober and ambitious agenda for accelerating progress in cancer research.
In Brief


Funding Opportunities
Clinical Roundup


Drugs & Targets


Trending Stories
- Otis Brawley looks back on a year of great science and greater challenges
- Elisa Rodriguez named first chief diversity and equity officer for faculty at Roswell Park
- Mikaela Naylon Give Kids a Chance Act nixed by Senate
- Gregory Curt, Clinician and Drug Developer, Dies at 64
- Twitter star Vinay Prasad retires @VinayPrasadMD
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program














